Disclosures for "Patients with Multiple Sclerosis in Year 5 After Initiation of Treatment with Cladribine Tablets: Analysis of Longitudinal Prescription Data from Germany"
-
Ms. Dr. Von Der Maßen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for IQVIA.
-
-
Michael Huebschen has received personal compensation for serving as an employee of Merck Healthcare Germany. Michael Huebschen has received personal compensation for serving as an employee of Esai Deutschland. Michael Huebschen has received personal compensation for serving as an employee of Eisai Schweiz GmbH. Michael Huebschen has received personal compensation for serving as an employee of Novartis Pharma Schweiz Ag. Michael Huebschen has stock in Merck. Michael Huebschen has stock in Sandoz. Michael Huebschen has stock in Novartis.
-
Dr. Wagner has received personal compensation for serving as an employee of Merck Healthcare Germany GmbH .
-
Mrs. Tundia has received personal compensation for serving as an employee of EMD Serono.
-
Ms. Russel-Szymczyk has received personal compensation for serving as an employee of Merck Sp. z o.o. An immediate family member of Ms. Russel-Szymczyk has received personal compensation for serving as an employee of GSK. Ms. Russel-Szymczyk has stock in Novo Nordisk.